Printer-friendly versionPDF versionSend to friend

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.

TitleEthnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study.
Publication TypeJournal Article
Year of Publication2009
AuthorsMak K-, Bhatt DL, Shao M, Hankey GJ, Easton DJ, Fox KA, Topol EJ
JournalAmerican heart journal
Volume157
Issue4
Pagination658-65
Date Published2009 Apr
ISSN1097-6744
KeywordsAged, Atherosclerosis, Cause of Death, Double-Blind Method, Ethnic Groups, Female, Follow-Up Studies, Hemorrhage, Humans, Incidence, Male, Middle Aged, Myocardial Ischemia, Platelet Aggregation Inhibitors, Prognosis, Prospective Studies, Risk Factors, Stroke, Ticlopidine, Time Factors, United States
AbstractAtherothrombosis is a common condition affecting individuals worldwide. Its impact on different ethnic groups receiving evidence-based therapy is unclear. We aimed to determine if ethnicity is an independent predictor for cardiovascular events and bleeding complications in a contemporary clinical trial on antiplatelet therapy.
Alternate JournalAm. Heart J.